Autor: Firma ANERGIS SA

Anergis and Virometix Announce Research Collaboration to Use Synthetic Virus-Like Particles for Ultra-Fast Allergy Immunotherapy

Firma ANERGIS SAPosted in Forschung und EntwicklungTagged , , , , , , , , , , , , , ,

Anergis SA, a company developing Contiguous Overlapping Peptides (COPs) for ultra-fast allergy immunotherapy, and Virometix AG, a company developing a new generation of vaccines and immunotherapeutic drugs, announced today that […]

Weiterlesen